Who Buys Simvastatin from India — 421 Importers Behind a $125.9M Market
India's simvastatin import market is served by 421 active buyers who collectively imported $125.9M across 3,854 shipments. MYLAN HUNGARY KFT, (HUNGARY) leads with a 20.0% market share, followed by YUSEN LOGISTICS BENELUX BELGIUM and APL SWIFT SERVICES (MALTA) LTD.,. The top 5 buyers together control 34.5% of total import value, reflecting a moderately competitive buyer landscape.
Top Simvastatin Importers — Ranked by Import Value
MYLAN HUNGARY KFT, (HUNGARY) is the leading simvastatin importer from India, holding a 20.0% share of the $125.9M market across 3,854 shipments from 421 buyers. The top 5 buyers — MYLAN HUNGARY KFT, (HUNGARY), YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), APL SWIFT SERVICES (MALTA) LTD., (MALTA), AMB HK ENTERPRISES INC. (PHILIPPINES), XXROBXXDO XXARMXXUSAXXNC (UNITED STATES) — collectively control 34.5% of total import value.
Top Simvastatin Buyers & Importers
Ranked by import value · 421 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | MYLAN HUNGARY KFT,HUNGARY SIMVASTATIN TABLETS 10MGHARMLESS MEDICINES, SIMVASTATIN TABLETSEZETIMIBE/SIMVASTATINE MYLAN 10MG/20MG 9 | $25.2M | 5 | 20.0% |
| 2 | YUSEN LOGISTICS BENELUX BELGIUMBELGIUM SIMVASTATIN TABLETS 20MG ( SIMVA BASICSSIMVASTATIN TABLETS 40MG ( SIMVA BASICS | $8.9M | 5 | 7.1% |
| 3 | APL SWIFT SERVICES (MALTA) LTD.,MALTA SIMVASTATIN 10MG TABLETS(SIMVASTATINA AUSIMVASTATIN TABLETS 20MG(SIMVASTATINA AUSIMVASTATIN TABLETS 20MG(SINVASTATINA AU | $5.6M | 5 | 4.5% |
| 4 | AMB HK ENTERPRISES INC.PHILIPPINES SIMVASYN 40 - SIMVASTATIN 40MG FILM-COATED TABLETSIMVASTATIN 10MG TABLETS 273969 X 2 X 14SIMVASTATIN 40MG FILM COATED TABLETS(2X1 | $2.5M | 5 | 2.0% |
| 5 | XXROBXXDO XXARMXXUSAXXNCUNITED STATES SIMVASTATIN 40 MG TABLETS 1000'S PACKSIMVASTATIN TABLETS USP 40MG US R1 SISIMVASTATIN TABLET | $1.2M | 5 | 0.9% |
| 6 | ORION CORPORATION,FINLAND | $1.1M | 5 | 0.9% |
| 7 | FAWDON MANUFACTURING CENTRE ( SF )UNITED KINGDOM SIMVASTATIN 10MG TABLETS 273969 X 2 X 14SIMVASTATIN 40MG FILM COATED TABLETS(2X1 | $986.5K | 5 | 0.8% |
| 8 | MYLAN HUNGARY KFTHUNGARY SIMVASTATIN TABLETS 10MGHARMLESS MEDICINES, SIMVASTATIN TABLETSEZETIMIBE/SIMVASTATINE MYLAN 10MG/20MG 9 | $888.7K | 5 | 0.7% |
| 9 | XXRTHXXAR XXALTXXAREXUNITED STATES SIMVASTATIN 40 MG TABLETS 1000'S PACKSIMVASTATIN TABLETS USP 40MG US R1 SISIMVASTATIN TABLET | $822.7K | 5 | 0.7% |
| 10 | APOTEX PTY LIMITEDAUSTRALIA SIMVAR 80 TABLETOTHERS : APO-EZETIMIBE/SIMVASTATIN 10/80SIMVASTATIN TABLETS 80 MG PACKS 8500'SBSP | $822.2K | 5 | 0.7% |
| 11 | ARROW PHARMACEUTICALS PTY LTDAUSTRALIA EZETIMIBE/SIMVASTATINE MYLAN 10MG/20MG 9SIMVAR 80 TABLETEZETIMIBE/SIMVASTATINE MYLAN 10MG/40MG 9 | $752.9K | 5 | 0.6% |
| 12 | ASCEND LABORATORIES LLCUNITED STATES SIMVASTATIN 40 MG TABLETS 1000'S PACKSIMVASTATIN TABLETS USP 40MG US R1 SISIMVASTATIN TABLET | $714.9K | 5 | 0.6% |
| 13 | U.N.R.W.A.JORDAN | $690.7K | 5 | 0.5% |
| 14 | ASCEND LABORATORIES,LLCUNITED STATES SIMVASTATIN 40 MG TABLETS 1000'S PACKSIMVASTATIN TABLETS USP 40MG US R1 SISIMVASTATIN TABLET | $684.1K | 5 | 0.5% |
| 15 | APOTEX AUSTRALIAAUSTRALIA SIMVAR 80 TABLETOTHERS : APO-EZETIMIBE/SIMVASTATIN 10/80SIMVASTATIN TABLETS 80 MG PACKS 8500'SBSP | $672.1K | 5 | 0.5% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Simvastatin — and from which countries?
Flow of Simvastatin exports from India: each country's share and the named importers behind the numbers
Simvastatin — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $36.5M through 84 shipments. This represents a market share of 29.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• XXROBXXDO XXARMXXUSAXXNC - $1.2M (3.2% of country's total business)
• XXRTHXXAR XXALTXXAREX - $822.7K (2.3% of country's total business)
• ASCEND LABORATORIES LLC - $714.9K (2.0% of country's total business)
• ASCEND LABORATORIES,LLC - $684.1K (1.9% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $434.4K, indicating premium pricing strategy compared to the market average of $32.7K.
United States is a key market for Simvastatin imports, representing 29.0% of total trade value.
2Hungary
Hungary emerges as the second largest importing country, achieving a total trade value of $26.8M through 54 shipments. This represents a market share of 21.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Hungary has a diverse importer base, with their top importers including:
• MYLAN HUNGARY KFT, - $25.2M (94.0% of country's total business)
• MYLAN HUNGARY KFT - $888.7K (3.3% of country's total business)
Key Insight: Hungary demonstrates strong market positioning with an average shipment value of $497.0K, indicating premium pricing strategy compared to the market average of $32.7K.
Hungary is a key market for Simvastatin imports, representing 21.3% of total trade value.
3New Zealand
New Zealand emerges as the third largest importing country, achieving a total trade value of $13.9M through 0 shipments. This represents a market share of 11.0% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: New Zealand demonstrates strong market positioning with an average shipment value of $13.9M, indicating premium pricing strategy compared to the market average of $32.7K.
New Zealand is a key market for Simvastatin imports, representing 11.0% of total trade value.
4Belgium
Belgium emerges as the fourth largest importing country, achieving a total trade value of $9.4M through 368 shipments. This represents a market share of 7.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Belgium has a diverse importer base, with their top importers including:
• YUSEN LOGISTICS BENELUX BELGIUM - $8.9M (94.6% of country's total business)
Key Insight: Belgium demonstrates strong market positioning with an average shipment value of $25.5K, indicating competitive pricing strategy compared to the market average of $32.7K.
Belgium is a key market for Simvastatin imports, representing 7.5% of total trade value.
5Malta
Malta emerges as the fifth largest importing country, achieving a total trade value of $7.3M through 295 shipments. This represents a market share of 5.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Malta has a diverse importer base, with their top importers including:
• APL SWIFT SERVICES (MALTA) LTD., - $5.6M (76.9% of country's total business)
Key Insight: Malta demonstrates strong market positioning with an average shipment value of $24.9K, indicating competitive pricing strategy compared to the market average of $32.7K.
Malta is a key market for Simvastatin imports, representing 5.8% of total trade value.
Buyer Segment Analysis
TransData Nexus Simvastatin buyer market intelligence
1Buyer Segment Analysis
The importation of Simvastatin from India involves various buyer segments, each with distinct purchasing behaviors and order patterns.
Distributors: Entities like MYLAN HUNGARY KFT (Hungary) and YUSEN LOGISTICS BENELUX BELGIUM (Belgium) function as intermediaries, procuring large quantities of Simvastatin for distribution to pharmacies, hospitals, and healthcare providers. Their purchasing behavior is characterized by bulk orders to achieve economies of scale, with a focus on maintaining a consistent supply chain to meet market demand.
Contract Manufacturers: Companies such as APL SWIFT SERVICES (MALTA) LTD. (Malta) and FAWDON MANUFACTURING CENTRE (SF) (United Kingdom) import Simvastatin as an active pharmaceutical ingredient (API) for the production of finished dosage forms. Their procurement patterns are aligned with production schedules, ensuring a steady supply of API to meet manufacturing timelines and regulatory requirements.
Re-exporters: Entities like YUSEN LOGISTICS BENELUX BELGIUM (Belgium) may also act as re-exporters, importing Simvastatin for subsequent distribution to other markets. This segment focuses on leveraging strategic geographic locations and trade agreements to facilitate the movement of pharmaceuticals across borders, often dealing with varying regulatory landscapes and market demands.
Government Procurement: While not explicitly listed among the top 10 buyers, government agencies and international organizations such as UNICEF and the Global Fund engage in tender-based purchasing of Simvastatin to support public health initiatives. Their procurement processes are typically characterized by large-volume orders, stringent quality assessments, and adherence to international procurement guidelines to ensure the availability of essential medicines in public healthcare systems.
Country-Specific Import Regulations
TransData Nexus Simvastatin buyer market intelligence
1Country-Specific Import Regulations
United States:
Hungary:
New Zealand:
Belgium:
Malta:
Demand Drivers & Market Opportunity
TransData Nexus Simvastatin buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Simvastatin in importing countries is primarily driven by the prevalence of hypercholesterolemia and associated cardiovascular diseases. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, accounting for approximately 17.9 million deaths annually as of 2023. The widespread incidence of these conditions necessitates effective lipid-lowering therapies like Simvastatin.
Government healthcare programs and the expansion of universal health coverage further bolster demand. Many countries have included Simvastatin in their national essential medicines lists, aligning with the WHO's Essential Medicines List, which was last updated in 2023. This inclusion facilitates procurement through tender-based purchasing mechanisms, ensuring the availability of affordable medications in public healthcare systems. The presence of 421 buyers across 84 countries, as per our data, underscores the global reach and sustained demand for Simvastatin.
Common Questions — Simvastatin Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest simvastatin buyer importing from India?
Based on import volume and value, MYLAN HUNGARY KFT, (HUNGARY) leads with $25.2M in imports and a 20.0% market share — the highest of any single simvastatin importer. YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) and APL SWIFT SERVICES (MALTA) LTD., (MALTA) are the next largest buyers.
QHow many companies buy simvastatin from India?
There are 421 active simvastatin buyers importing from India, with a combined market of $125.9M across 3,854 shipments to 84 countries. The top 5 buyers hold 34.5% of total import value, while the remaining 416 buyers handle the other 65.5%.
QWhich countries import the most simvastatin from India?
The top importing countries for simvastatin from India are United States (29.0%), Hungary (21.3%), New Zealand (11.0%), Belgium (7.5%), Malta (5.8%). These markets represent the largest demand centres for Indian pharmaceutical exports of simvastatin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for simvastatin from India?
The average import transaction value for simvastatin from India is $32.7K, with an average unit price of $39.96 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Simvastatin buyer market intelligence
1Buyer Segment Analysis
The importation of Simvastatin from India involves various buyer segments, each with distinct purchasing behaviors and order patterns.
Distributors: Entities like MYLAN HUNGARY KFT (Hungary) and YUSEN LOGISTICS BENELUX BELGIUM (Belgium) function as intermediaries, procuring large quantities of Simvastatin for distribution to pharmacies, hospitals, and healthcare providers. Their purchasing behavior is characterized by bulk orders to achieve economies of scale, with a focus on maintaining a consistent supply chain to meet market demand.
Contract Manufacturers: Companies such as APL SWIFT SERVICES (MALTA) LTD. (Malta) and FAWDON MANUFACTURING CENTRE (SF) (United Kingdom) import Simvastatin as an active pharmaceutical ingredient (API) for the production of finished dosage forms. Their procurement patterns are aligned with production schedules, ensuring a steady supply of API to meet manufacturing timelines and regulatory requirements.
Re-exporters: Entities like YUSEN LOGISTICS BENELUX BELGIUM (Belgium) may also act as re-exporters, importing Simvastatin for subsequent distribution to other markets. This segment focuses on leveraging strategic geographic locations and trade agreements to facilitate the movement of pharmaceuticals across borders, often dealing with varying regulatory landscapes and market demands.
Government Procurement: While not explicitly listed among the top 10 buyers, government agencies and international organizations such as UNICEF and the Global Fund engage in tender-based purchasing of Simvastatin to support public health initiatives. Their procurement processes are typically characterized by large-volume orders, stringent quality assessments, and adherence to international procurement guidelines to ensure the availability of essential medicines in public healthcare systems.
Country-Specific Import Regulations
TransData Nexus Simvastatin buyer market intelligence
1Country-Specific Import Regulations
United States:
Hungary:
New Zealand:
Belgium:
Malta:
Demand Drivers & Market Opportunity
TransData Nexus Simvastatin buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Simvastatin in importing countries is primarily driven by the prevalence of hypercholesterolemia and associated cardiovascular diseases. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, accounting for approximately 17.9 million deaths annually as of 2023. The widespread incidence of these conditions necessitates effective lipid-lowering therapies like Simvastatin.
Government healthcare programs and the expansion of universal health coverage further bolster demand. Many countries have included Simvastatin in their national essential medicines lists, aligning with the WHO's Essential Medicines List, which was last updated in 2023. This inclusion facilitates procurement through tender-based purchasing mechanisms, ensuring the availability of affordable medications in public healthcare systems. The presence of 421 buyers across 84 countries, as per our data, underscores the global reach and sustained demand for Simvastatin.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 421 global importers of Simvastatin identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 3,854 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 84 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,854 Verified Shipments
421 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists